Anjali Baichwal

Neuroscientist Graham Collingridge is new director of �鶹��Ƶ's Tanz Centre

noreen.rasbach — Tue, 17 Sep 2019 04:00:00 +0000

Neuroscientist Graham Collingridge is new director of �鶹��Ƶ's Tanz Centre noreen.rasbach Tue, 09/17/2019 - 00:00

Cutline

Professor Graham Collingridge was one of three recipients of The Brain Prize in 2016, the world’s most prestigious neuroscience award

Anjali Baichwal

Topic

Our Community

Faculty of Medicine

Governing Council

Learning

Memory

Subheadline

Professor Graham Collingridge, a world-renowned expert in learning and memory, has taken over as the new director of the Tanz Centre for Research in Neurodegenerative Diseases.

Collingridge works in the area of synaptic plasticity, which is considered the neural basis of learning and memory. His research identifies the molecules and mechanisms in the brain that underlie learning and memory to determine how errors in the process of brain cell signalling and flexibility contribute to major brain disorders such as Alzheimer’s disease, multiple sclerosis and fragile X syndrome.

In 2016, he was one of three recipients of The Brain Prize, considered the world’s most prestigious neuroscience award, bestowed by the Lundbeck Foundation in Denmark. The award recognizes Collingridge’s research into “long-term potentiation,” a model for understanding how memories form. Earlier this year, Collingridge was appointed commander of the Order of the British Empire for his contributions to biomedical science.

“We are so pleased to have attracted someone of Graham’s calibre to lead the Tanz Centre,” says Professor Trevor Young, dean of the Faculty of Medicine. “His deeply impressive body of research into the neuroscience of learning and memory and its role in brain disorders holds great promise in helping millions of people affected by Alzheimer’s and other devastating neurological conditions.”

Under the direction of Dr. Peter St George-Hyslop, who served as director from 1990 to 2019, the Tanz Centre has become a global leader in neurodegenerative disease research, transforming our understanding of Alzheimer’s disease and other dementias, Parkinson’s disease, ALS, prion diseases and other neurodegenerative conditions.

“Peter is a giant in the field of neuroscience,” says Collingridge. “When he began his pioneering research into Alzheimer’s in the 1980s, the disease was little understood. Today, thanks to Peter’s leadership and the Tanz Centre’s approach to pursuing basic scientific discoveries and translating these into therapies, we are able to more definitively diagnose and offer better treatment options to those suffering from these dreadful disorders of the central nervous system.”

Collingridge and his team hope to build on the Tanz Centre’s success by focusing on promoting excellence in research and fostering collaborations withinthe centre, across the Toronto Academic Health Science Network (TAHSN), and internationally.

“My first goal is to maintain and build upon the scientific excellence at the Tanz Centre by defining long-term objectives and securing the funding to bring even more outstanding investigators to work here,” says Collingridge. “Neurodegenerative disease is a huge problem facing people all over the world, and trying to understand the root causes is best tackled with collaborative, multinational efforts. Here in Toronto and Canada, we are extremely well positioned to do just that.”

From the outset, philanthropy has played an essential role in establishing and supporting the Tanz Centre and the leading researchers who work there.

After witnessing his mother Gertrude suffer from Alzheimer’s disease, Mark Tanz was determined to speed the progress of Canada’s research efforts to address the debilitating condition. In 1987, he donated $3.4 million to help establish the Tanz Centre. Since that time, he has contributed an additional $6.1 million to support the Centre.

Jacqueline and Mark Tanz

More recently, the Tanz Centre once again benefited from the support of a visionary group of donors, including a $2-million gift from the Krembil Foundation to establish the Krembil Family Chair in Alzheimer’s Research, to be held by Collingridge as the centre’s director. A commitment of $1.5-million from Mark Tanz’s son, Stuart Tanz, will provide critical support for the Director’s Priority Fund.

Stuart Tanz, who recently assumed his father’s role as chair of the Tanz Centre steering committee, says it’s a great honour to continue his father’s legacy. “It is enormously gratifying and a great privilege to represent my family and fulfil my father’s vision to boost global research and education in neurodegenerative disease,” he says.

Mark Krembil, president and CEO of the Krembil Foundation, who also serves on the board of Brain Canada, �鶹��Ƶ’s Governing Council and on the Tanz Centre steering committee, believes that groundbreaking discovery requires both recognition and support.

“We have great faith in Professor Collingridge’s ability to oversee the exciting next chapter of the Tanz Centre story,” he says. “Our combined support was our way to ensure the centre remains at the forefront of international efforts to untangle the brain’s mysteries.”

This generous donor support that led to bringing Collingridge to the Tanz Centre will enable the centre and its researchers to harness more effectively the knowledge and resources needed to drive discovery.

“It is an incredible honour to take over the helm of such an outstanding research centre as the Tanz,” says Collingridge. “Few places worldwide are as well positioned as the University of Toronto to lead the global effort to understand, treat and prevent these complex neurodegenerative conditions. I look forward to building our network of researchers, and to the continued support of our community to help us make significant progress in such a socio-economically important field.”

Eaton family's $1 million gift marks a century of support for �鶹��Ƶ's Faculty of Medicine

Christopher.Sorensen — Mon, 21 Jan 2019 17:05:36 +0000

Eaton family's $1 million gift marks a century of support for �鶹��Ƶ's Faculty of Medicine

Christopher.Sorensen Mon, 01/21/2019 - 12:05

Cutline

Professor Gillian Hawker, who holds the Sir John and Lady Eaton Professor and Chair of Medicine, and John Craig Eaton II, who donated $1 million to �鶹��Ƶ's department of medicine (photo by Kenneth Chou)

Topic

Research & Innovation

The University of Toronto’s department of medicine recently received a $1 million gift from John Craig Eaton II in support of the Eliot Phillipson Clinician-Scientist Training Program – equipping new generations of physicians to advance our understanding of disease through research.

The commitment comes as the Faculty of Medicine, which oversees the department of medicine and several other departments, celebrates the 100th anniversary of the original gift – from Eaton’s grandparents – that supported the Sir John and Lady Eaton Professor and Chair of Medicine, and marked �鶹��Ƶ’s first endowed chair and the British Empire’s first chair in medicine.

“Over the past century, the Eaton chair has played a significant role in placing the faculty and department at the forefront of life-changing health research and innovation,” says Professor Gillian Hawker, who currently holds the chair.

Prior to the chair’s creation, busy clinicians would carve out time from their paid clinical work to serve as educators or pursue research – areas that offered little or no compensation.

“There was no system or structure to support physicians who wanted to teach and do research,” Hawker says.

“Physicians wanting to play an extra role in teaching or research were doing it in their spare time, after hours. The concept of ‘academic physician’ did not exist.”

Things began to change when the Carnegie Foundation commissioned a seminal study of the state of medical education in the United States and Canada in 1908. The resulting Flexner Report helped establish the biomedical model that we now recognize as the gold standard for medical training.

Dr. William Goldie, a member of the �鶹��Ƶ’s department of medicine and a highly respected clinician at Toronto General Hospital, was a big proponent of the report. He persuaded �鶹��Ƶ and the hospital to hire a full-time professor of medicine – a physician who would see patients, conduct research and teach students. He also reached out to the Eatons, who donated $500,000 to endow the professorship permanently. The amount is equivalent to $6.7 million today.

“The Eaton endowment was ground-breaking,” says Hawker. “Not only did it give the chair-holder the freedom to teach and conduct research, it enabled major recruitment of leading academic physicians and expansion of laboratory research.”

The Eaton investment helped transform �鶹��Ƶ’s department of medicine into a training ground for clinician-scientists – a shift that profoundly influenced medical education and discovery throughout Canada. It paved the way for academic physicians, post-graduate medical training, full-time clinician-scientists, affiliated teaching hospitals and clinical research units, including the clinical investigation unit where insulin was first injected into a patient.

“Dr. Goldie’s vision for medical research and education and the creation of the Eaton professor and chair are a big part of our roots,” says Hawker. “I think that’s why internal medicine has been so successful from a research and teaching perspective.”

Today, �鶹��Ƶ’s department of medicine is one of the largest in North America, training one-third of Canada’s – and one-half of Ontario’s – internal medicine specialists. With 800 full-time faculty members, 1,000 post-graduate trainees, and 20 specialty and sub-specialty divisions, it is the research and educational hub connecting six fully affiliated hospitals, four community-affiliated hospitals and more than a dozen additional clinical practice sites.

The department is also a research powerhouse, generating more than $160 million in research funding annually.